Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.210
+0.250 (12.76%)
At close: Nov 1, 2024, 4:00 PM
2.230
+0.020 (0.90%)
After-hours: Nov 1, 2024, 6:02 PM EDT

Caribou Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-123.44-102.07-99.42-66.92-34.31-23.43
Depreciation & Amortization
3.893.531.620.980.90.75
Loss (Gain) From Sale of Assets
--0.03-00.070
Asset Writedown & Restructuring Costs
1.63-0.613.13-
Loss (Gain) From Sale of Investments
-3.2-4.42-0.660.050.73-2.29
Stock-Based Compensation
15.7613.7511.723.4511.23
Other Operating Activities
0.163.28-0.62-0.15-4.92-
Change in Accounts Receivable
1.060.880.19-1.16-0.64-0.22
Change in Accounts Payable
0.131.82-2.721.140.041.18
Change in Unearned Revenue
-23.69-16.94-4.8429.64-0.61-0.8
Change in Other Net Operating Assets
7.296.753.26-0.871.87-1.31
Operating Cash Flow
-120.24-93.29-90.97-32.52-33.22-32.01
Capital Expenditures
-10.72-11.61-6.45-2.12-0.32-0.88
Sale of Property, Plant & Equipment
----0.01-
Sale (Purchase) of Intangibles
-1.63--0.6-1-1-
Investment in Securities
-43.45-56.57-86.2-173.287.6728.12
Investing Cash Flow
-55.79-68.18-93.25-176.46.3627.23
Long-Term Debt Issued
---1.151.58-
Long-Term Debt Repaid
----0.12-0.11-0.05
Net Debt Issued (Repaid)
---1.031.47-0.05
Issuance of Common Stock
147.7154.32.13323.570.270.22
Financing Cash Flow
147.7154.32.13433.431.740.17
Net Cash Flow
-28.33-7.18-182.08224.51-25.12-4.6
Free Cash Flow
-130.95-104.9-97.42-34.64-33.53-32.89
Free Cash Flow Margin
-395.48%-304.27%-703.34%-360.91%-271.27%-568.24%
Free Cash Flow Per Share
-1.49-1.42-1.60-1.09-3.92-3.93
Cash Income Tax Paid
-0.17-0.010.021.81
Levered Free Cash Flow
-84.73-64.36-56.11-33.46-21.16-
Unlevered Free Cash Flow
-84.73-64.36-56.11-33.46-21.15-
Change in Net Working Capital
3.54-2.51-4.11-7.09-0.84-
Source: S&P Capital IQ. Standard template. Financial Sources.